| Respiratory Panel by PCR (8000101169) | |
|---|---|
| Test Mnemonic: | RPPCR |
| Specimen Requirements: | Nasopharyngeal (NP) swab in viral/universal transport media |
| Test Included: | Panel for the detection of:
|
| Collection: | Standard collection and handling procedures used to collect nasopharyngeal swab are appropriate. Swabs are placed into viral/universal transport media. |
| Container: | NP swab – swab in viral/universal transport media |
| Minimum Volume: | 1 mL |
| Storage/Transport: | Specimen should be delivered to the lab ASAP. Storage for up to 4 hours at room temperature; then, refrigerate. |
| Stability: | Refrigerated up to 3 days. |
| Causes for Rejection: | Specimens must meet criteria set forth in the Laboratory Services Specimen Labeling and Requests for Testing policy. Specimens are canceled as duplicates if the patient was previously tested: - Within 7 days – Pediatric patient (< 12 years old). - Within 14 days – Adult patient. This test is primarily for use on hospital inpatients and patients seen by the Pulmonary and Infectious Diseases specialties. Otherwise, Microbiology Director approval is required. Specimens are canceled as duplicates if the patient has tested positive for influenza A, influenza B, and/or RSV. |
| Reference Range: | Negative |
| Turnaround Time: | 1 - 2 days |
| Methodology: | Multiplex Polymerase Chain Reaction (PCR) |
| Performed: | |
| Lab: | Clinical Microbiology |
| Synonyms: | Adeno, ADV, Adenovirus, Coronavirus, hMPV, MPV, Human Metapneumovirus, Metapneumovirus, Rhinovirus, Enterovirus, EV, Influenza, Influenza A, Influenza B, Flu A, Flu B, Flu, Parainfluenza, Paraflu, PIV, Respiratory Syncytial Virus, RSV, Bordetella, Bordetella parapertussis, Bordetella pertussis, Whooping, Whooping cough, Pertussis, Chlamydia pneumoniae, Chlamydophila, Mycoplasma, Mycoplasma pneumoniae, Upper Respiratory, Respiratory Virus |
| Clinical Indication: | This test is used to detect respiratory pathogens – adenovirus, coronavirus, human metapneumovirus, human rhinovirus/enterovirus, influenza A, influenza B, parainfluenza, respiratory syncytial virus, Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae. |
| CPT 4 Code: | 87633 87798 x 2 87486 87581 |
| Note: | A negative result should not rule-out infection in patients with a high pretest probability for respiratory infection. The assay does not test for all potential infectious agents of respiratory infection. Positive results do not distinguish between a viable organism and the presence of a nonviable organism or nucleic acid. Results of the panel are intended to aid in the diagnosis of illness and are meant to be used in conjunction with other clinical and epidemiological findings. There may be public health requirements that requires reporting as a notifiable condition. NP viral/universal transport collection kits available through Materials Management or by contacting Laboratory Client Services. |
| When ordering tests for which Medicare or Medicaid reimbursement will be sought, physicians should only order tests that are medically necessary for the diagnosis or treatment of the patient. Components of the organ or disease panels may be ordered individually. The diagnostic information must substantiate all tests ordered and must be in the form of an ICD-10 code or its verbal equivalent. | |